Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07538570
PHASE4
Evaluation of Pain Treatment After Total Knee Arthroplasty
Sponsor: Vertex Pharmaceuticals Incorporated
View on ClinicalTrials.gov
Summary
The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).
Official title: A Phase 4, Double-blind, Sequential Cohort Study of Pain Treatment and Recovery After Total Knee Arthroplasty
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-04-24
Completion Date
2027-01-30
Last Updated
2026-05-13
Healthy Volunteers
No
Conditions
Interventions
DRUG
Suzetrigine
Tablets for oral administration.
DRUG
Placebo
Placebo matched to SUZ for oral administration
Locations (2)
Legent Orthopedic and Spine Hospital
Bellaire, Texas, United States
Memorial Hermann Village Office
Houston, Texas, United States